Czibere Akos insider trades
Czibere Akos has filed 2 Form 4s with the SEC that we hold, all for Aktis Oncology, Inc. (AKTS), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 5 sales worth $1.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($1.6M). The largest single trade was a sale of 30,829 shares of Aktis Oncology, Inc. worth $861.7K, dated 2026-07-08. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2026-07-10 and the latest 2026-09-24.
Aktis Oncology, Inc. (AKTS)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-07-08 | S, sale reported on Form 4 | 14,800 | $401.5K | 2026-07-10 | SEC |
| 2026-07-08 | S, sale reported on Form 4 | 30,829 | $861.7K | 2026-07-10 | SEC |
| 2026-07-08 | S, sale reported on Form 4 | 4,371 | $125.5K | 2026-07-10 | SEC |
| 2026-09-23 | S, sale reported on Form 4 | 5,099 | $103.0K | 2026-09-24 | SEC |
| 2026-09-23 | S, sale reported on Form 4 | 7,401 | $155.6K | 2026-09-24 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 2049427) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
